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Summary
Objective: The aim of this study was to describe some demographic, clinical and laboratory
characteristics, and to evaluate the outcome, in patients with brucellosis in an endemic area in
the Balkan Peninsula, and to reveal the differences between patients with and without occupa-
tional exposure.
Methods: The study was carried out at the Clinic for Infectious Diseases in Skopje over a period of
seven years. Four hundred and eighteen patients with brucellosis were enrolled and classified into
two groups: patients with (251) and without (167) occupational exposure.
Results: Two hundred and twenty-eight (54.5%) of the patients had a positive family history. The
most common clinical manifestations were arthralgia (81.8%), sweating (71.5%), localized disease
(67.7%) and subjective fever (68.4%), whereas elevated values of C-reactive protein (78.9%) and
circulating immune complexes (75.8%) were the most frequent laboratory abnormalities.
Relapses and therapeutic failure were registered in 16.2% and 10.4%, respectively. Male gender,
positive family history and arthralgia were more prevalent in those with occupational exposure,
while pediatric age, fever and anemia were inversely correlated with occupational exposure.
Conclusions: Human brucellosis is a serious problem in the Republic of Macedonia presenting with
a high percentage of localized forms, relapses and therapeutic failures. The risk factor for
acquiring the disease had no influence on the outcome.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +389 2 2777 237; fax: +389 2 2655 855.
E-mail address: mbosilkovski@yahoo.com (M. Bosilkovski).
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Brucellosis is one of more than 166 recognized zoonoses,1
considered by the Food and Agricultural Organization (FAO),Published by Elsevier Ltd. All rights reserved.
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national des Epizooties (OIE) as themost widespread zoonosis
globally.2 In endemic regions brucellosis is recognized to have
an important impact on human and animal health, economic
development, agricultural trade and even tourism.3
Humans acquire the infection through the consumption of
products of infected animals such as unpasteurized milk,
cheese and insufficiently cooked or raw meat.3 Infection
may also result from the entry of the bacteria from diseased
animals or their secretions through skin lesions, conjunctiva
or from inhalation of contaminated dust or aerosols.3,4 This is
especially common in occupationally exposed persons.5,6
In humans, brucellosis behaves as a systemic infection
with a very heterogeneous clinical spectrum, which led
Simpson in the 1940s to remark: ‘‘no disease, not excepting
syphilis and tuberculosis, is more protean in its manifesta-
tions’’.7 In some situations, focal forms, relapses, a pro-
tracted clinical course, and therapeutic failures are found
even when the disease has been recognized in a timely
manner and has been adequately treated.
The aim of this study was to describe some demographic,
clinical and laboratory characteristics, and to evaluate the
outcome, in patients with brucellosis in an endemic area in
the Balkan Peninsula in relation to mode of exposure (occu-
pational and non-occupational).
Patients and methods
Patients
The study included 418 consecutive patients with brucellosis
who were diagnosed and treated at the Clinic for Infectious
Diseases in Skopje in the period January 1998—December
2004. The Clinic for Infectious Diseases is the only academic
tertiary care hospital in the Republic of Macedonia, serving a
population of 2 million people.
Diagnosis of brucellosis
Brucellosis was diagnosed, as previously described,8,9 on the
basis of clinical symptoms and signs compatible with brucel-
losis, supported by detection of specific antibodies (standard
tube agglutination test and anti-brucella Coombs’ test) at
significant titers and/or demonstration of an at least four-
fold rise in antibody titer in serum specimens obtained 3 to 4
weeks apart.
Patient data
Demographic, clinical, and laboratory data, and information
on history of occupational exposure to brucellosis were
collected for all patients according to the study protocol.
Erythrocyte sedimentation rate, complete blood count,
blood chemistry profile, circulating immune complexes,
and C-reactive protein were examined in all patients.
A radiographic study of the spine, sacroiliac joints, and
other osteoarticular locations was performed for each
patient with relevant symptoms and signs, and a radio-
nuclide bone scan with technetium99 methylene diphospho-
nate and/or computed tomography (CT) or magnetic
resonance imaging (MRI) were performed in cases with aclinical suspicion of deep osteoarticular location. All
patients underwent chest X-ray, electrocardiography, and
abdominal ultrasound investigation. Cardiovascular or uro-
genital involvement was excluded/confirmed by ultrasound
investigation of the respective regions. Computed tomo-
graphy of the brain, lumbar puncture, and electromyogra-
phy were performed for the clinical suspicion of
neurobrucellosis.
Treatment
The patients were treated with various antimicrobial com-
binations consisting of: oral doxycycline 100—200 mg/day in
patients 8 years old; oral rifampin 600—900 mg/day in
adults, 15—20 mg/kg/day in children; oral trimethoprim/
sulfamethoxazole 160/800—320/1600 mg/day in adults,
10—12/50—60 mg/kg/day in children; oral ciprofloxacin
1000 mg/day in adults; intramuscular gentamicin 240 mg/
day in adults, 5 mg/kg/day in children; intravenous ceftriax-
one 4 g/day in adults, 80 mg/kg/day in children.
Doxycycline, rifampin, trimethoprim/sulfamethoxazole
and ciprofloxacin when used, were administered for at least
45 days, gentamicin for the first 7—10 days, and ceftriaxone
only in patients with brucellar meningitis during the first 21
days. The choice depended on several conditions: clinical
presentation, age, pregnancy, drug side effects, tolerability
and/or availability. In patients with spondylitis, neurobru-
cellosis, endocarditis and those with therapeutic failure, the
duration of treatment lasted from 3months to up to one year.
Definitions
Occupational exposure to brucellosis was defined as direct
exposure to infected sheep, goats or cows, their blood,
secretions, excretions, or tissues for any patient, up to 6
months before the onset of illness.
Various types of localized forms of brucellosis were
defined according to criteria from previous studies: neuro-
brucellosis,10,11 osteoarticular,8,12 hematologic,13 respira-
tory,14 hepatic,15 endocarditis,11 orchitis and epididymitis.11
Therapeutic failure was defined as the persistence of
symptoms and signs attributable to the disease at the end
of a 45-day therapy, and relapse as the reappearance of
disease symptoms and signs after the antibrucellar treatment
was completed. Outcome was categorized as favorable
(recovery during the first therapeutic course) or unfavorable
(relapse, therapeutic failure). The outcome was evaluated
only in patients who had a follow-up period of at least 6
months post-therapy.
Follow-up
The patients were hospitalized until clinical improvement
was achieved. Laboratory and serological controls were con-
ducted on the 15th and 40th day of treatment. Over the
following three months, these check-ups were done once a
month, and then every 3—6 months. If necessary, controls
were made over shorter time periods if signs or symptoms of
relapse appeared or if there was worsening of the existing
signs and symptoms. In cases of relapse, the same diagnostic
and therapeutic procedures were performed as during the
initial episode.
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Table 1 Demographic and clinical characteristics in 418 patients with brucellosis, according to occupational exposure
Parameter Occupational
exposure (N = 251)
Non-occupational
exposure (N = 167)
p
Male gender 188 (74.9) 100 (59.9) 0.001
Positive family history 154 (61.4) 74 (44.3) 0.001
Age, years (mean  SD) 36.3  18.7 35.4  20.4 0.643
Illness duration prior to therapy, days (median; range) 30; 4—360 30; 3—360 0.488
Fever (symptom) 161 (64.1) 125 (74.8) 0.021
Headache 130 (51.8) 91 (54.5) 0.588
Arthralgia 216 (86.1) 126 (75.4) 0.006
Weight loss 68 (27.1) 34 (20.4) 0.116
Malaise 168 (66.9) 115 (68.9) 0.679
Sweating 183 (72.9) 116 (69.5) 0.444
Temperature at admission >37.5 8C (sign) 148 (59.0) 98 (58.7) 0.954
Hepatomegaly 130 (51.8) 77 (46.1) 0.255
Splenomegaly 78 (31.1) 38 (22.8) 0.063
Lymphadenopathy 75 (29.9) 43 (25.7) 0.358
Focal form 163 (64.9) 120 (71.8) 0.139
Data are n (%) unless otherwise stated.The evaluation of examined data was stratified according
to the mode of disease acquisition. Patients were classified
into two groups: (a) occupationally exposed and (b) non-
occupationally exposed.
Statistical analysis
Quantitative parameters that had normal distribution were
presented using mean and standard deviation, and for those
without normal distribution median and range values were
performed. The Chi-squared test was used for qualitative
variables. For quantitative variables the comparison was
performed using Student’s t-test (normal distribution) and
Mann—Whitney U test (not normal distribution). A p value
<0.05 was considered significant. Statistical analysis was
preformed using Statistical Package for Social Sciences (SPSS)
version 8.0.Table 2 Laboratory and serological data in 418 patients with br
Parameter Occupational
exposure (N =
Erythrocyte sedimentation
rate >20 mm/h
151 (60.2)
Anemia 94 (37.4)
Leukopenia 29 (11.6)
Leukocytosis 12 (4.8)
Lymphocytes >45% 85 (33.9)
Thrombocytopenia 10 (4.0)
Alanine aminotransferase >40 U/L 79 (31.5)
Circulating immune
complexes >0.05 g/L
191 (76.1)
C reactive protein >5 mg/L 205 (81.7)
Standard tube agglutination
test (median; range)
640; 80—1280
Anti-brucella Coombs test
(median; range)
1280; 80—5120
Data are n (%) unless otherwise stated.Results
Occupational exposure to brucellosis was recorded in 251
(60.0%) of 418 examined patients with brucellosis. In 54
(21.5%) subjects in this group, fresh cheese and raw milk
consumption were also recorded. The non-occupational
group consisted of 167 (40.0%) patients, and in 119 (71.3%)
of them ingestion of fresh cheese was recorded as the most
probable means of disease acquisition. Drinking of raw milk
and ingestion of undercooked goat and lamb meat was a
scarce event. However 48 (28.7%) patients in this group
denied ingestion of any suspect food.
The mean age of the patients was 36  19 (range 1—82)
years. In 113 (27.0%), the diagnosis was established within
two weeks after the onset of symptoms, and an additional
216 (51.7%) patients were diagnosed between two weeks and
two months following onset. The most common clinicalucellosis, according to occupational exposure
251)
Non-occupational
exposure (N = 167)
p
110 (65.9) 0.355
80 (47.9) 0.034
15 (9.0) 0.401
9 (5.4) 0.780
69 (41.3) 0.122
6 (3.6) 0.838
59 (35.3) 0.412
126 (75.4) 0.880
125 (74.8) 0.094
640; 80—1280 0.443
1280; 160—5120 0.377
Brucellosis in patients from the Balkan Peninsula 345
Table 5 Outcome and follow-up in 418 patients with bru-
cellosis, according to occupational exposure
Outcome Occupational
exposure
(N = 251)
Non-occupational
exposure
(N = 167)
p
Follow-up
(>6 months)
196 (78.1) 149 (89.2) 0.003
Favorable 143 (73) 110 (73.8) 0.490
Relapse 35 (17.9) 21 (14.1)
Therapeutic
failure
18 (9.2) 18 (12.1)
Data are n (%).
Table 3 Localized disease in 418 patients with brucellosis,
according to occupational exposure
Parameter Occupational
exposure
(N = 251)a
Non-occupational
exposure
(N = 167)b
Osteoarticular 142 (56.6) 93 (55.7)
Hematologic 14 (5.6) 15 (9.0)
Urogenital 20 (8.0) 9 (5.4)
Respiratory system 9 (3.6) 16 (9.6)
Nervous system 7 (2.8) 8 (4.8)
Hepatic 4 (1.6) 8 (4.8)
Cardiovascular system 6 (2.4) 3 (1.8)
Cutaneous 4 (1.6) 3 (1.8)
Data are n (%).
a Thirty-seven patients with two or more concomitant localized
forms.
b Thirty-three patients with two or more concomitant localized
forms.manifestations were arthralgia (81.8%), sweating (71.5%) and
subjective fever (68.4%).
Male gender and the presence of two or more infected
family members were significantly more prevalent in the
group that acquired the illness by means of occupational
exposure. Arthralgia and no fever (symptom) too, were more
frequent in this group (Table 1). Although there was no
difference in age distribution overall, a significant number
of patients without contact with animals were younger than
14 years when compared to the groupwith animal contact; 38
(22.8%) and 32 (12.8%), respectively ( p = 0.007).
The most frequent laboratory abnormalities in the exam-
ined patients were elevated values of: C reactive protein (in
78.9%), circulating immune complexes (in 75.8%), and ery-
throcyte sedimentation rate (in 62.4%). According to labora-
tory parameters, the only statistically significant difference
between the groups was for anemia (Table 2).
Osteoarticular brucellosis was by far the most common
localized form (Table 3). Some of these cases and some of the
patients with respiratory manifestations are discussed else-
where. The most common hematological manifestation was
anemia, although thrombocytopenic purpura and pancyto-
penia were also present. Urogenital localization was mainly
presented with orchitis and epididymitis, but pyelonephritis,
cystitis, and acute renal failure were present too. Radiculitis,
meningitis, myelitis, and peripheral and cranial neuritis were
the neurological manifestations recorded. Cardiovascular
forms consisted of myocarditis, endocarditis and vasculitis,Table 4 Antimicrobial combinations used in 418 patients with b
Therapeutic protocol Occupationa
exposure (N
Doxycycline + rifampin + trimethoprim
/sulfamethoxazole
190 (75.7)
Doxycycline + rifampin 24 (9.6)
Doxycycline + rifampin + gentamicin 12 (4.8)
Other 25 (10.0)
Data are n (%).and various types of rashes represented skin localization
(Table 3).
Most of the patients (78.7%) were treated with a combina-
tion of doxycycline, rifampin and trimethoprim/sulfa-
methoxazole. In the rest of the patients other therapeutic
regimens were used (Table 4). No significant difference was
evident between groups according to the therapeutic regi-
men used ( p = 0.064).
A follow-up period longer than 6 months was recorded in
345 (82.5%) cases, with a higher percentage in the non-
occupationally exposed patients ( p = 0.003) (Table 5).
Relapses occurred in 16.2% and therapeutic failure in
10.4% of the patients. A favorable outcome during the first
therapeutic course was found in 73.4%. The outcome was
almost the same in both groups.
One patient died as a direct consequence of brucellosis.
Three others died during the follow-up period, but the cause
was not brucellosis (myocardial infarction in two and hepatic
malignancy in one).
Discussion
The Republic of Macedonia is a small, developing country in
the central part of the Balkan Peninsula, with semi-nomadic
sheep and goat farming a predominant occupation, and a diet
that often consists of cheese prepared from raw milk. This
country represents an endemic area where brucellosis pre-
vails as a dominant zoonosis, and is a cause for high morbidity
and huge economic loss.9 The annual incidence of human
brucellosis in this country has been higher than 20 cases per
100 000 population for almost 20 years.8,9 The absence of an
animal vaccination program, erroneous implementation of
testing and slaughtering of infected animals, and inadequate
collaboration between the doctors and veterinarians are therucellosis, according to occupational exposure
l
= 251)
Non-occupational
exposure (N = 167)
p
139 (83.2) 0.064
6 (3.6)
4 (2.4)
18 (10.8)
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same time, the absence of adequate regulation/legislation
activities and the apathy of the farmers for collaboration due
to insufficient and irregular compensation for sacrificed ani-
mals, have also hindered attempts to control brucellosis.
Both Brucella melitensis biotypes 2 and 3 have been identi-
fied from some Macedonian patients in laboratories abroad.
The present study is the largest one in the Balkan Penin-
sula,16—18 and unique in comparing patients according to the
mode of disease acquisition. To our knowledge, this is the
only study showingmethod of exposure as a factor influencing
presentation and outcome.
Often the mode of disease acquisition remains an
enigma.19 Direct contact with infected animals is proven in
11—90%,20—22 and ingestion of contaminated food in 22—
94%11,15 of patients. In 53—62% of those with direct contact,
additional risk factors are also ingestion of inadequately
thermally processed products or airway transmission.12,23
However, in 12—57% patients, the origin of infection remains
unknown.11,21,24 This study has shown that the main risk
factor for brucellosis in the Republic of Macedonia is not
the consumption of animal products like in other endemic
countries,4,24,25 but working with animals, mainly sheep and
goats.
Experimental studies in some species of monkeys have
indicated that the minimum oral, inhalation and subcuta-
neous infective doses of B. melitensis are about 5000, 1300
and 325 organisms, respectively.26 It is estimated that in
humans the minimum infective doses are comparable.6 The
inoculum size due to livestock exposure is different from that
in ingestion. At the same time, occupational exposure offers
frequent, repetitive contact with the source of infection.
Wallach et al. stated that the frequency of contact with
probable sources of infection, rather than the type of work,
appeared to be the main contributory factor for contagion.5
Studies in abattoir workers, on the other hand, have shown
that repeated exposure to Brucella organisms might promote
immunity that would protect them from the severe symptoms
of brucellosis.27 Finally, recurrent contacts with infected
animals may lead to hypersensitivity.28
Taking into account the above-mentioned findings, one
would expect to observe variations in certain clinical and
laboratory findings, as well as in the outcome, depending on
the occupational or non-occupational form of disease acqui-
sition. Our expectations were also encouraged by the obser-
vation of Young who stated that: ‘‘susceptibility to infection
depends upon various factors, including. . . the size and route
of inoculum. . .’’.29 Hasanjani Roushan et al. too, have indi-
cated that the size of inoculum and route of acquisition are
important factors in determining the clinical presentation
and evolution of brucella infection.11
As expected, this study showed a significantly higher
association of male gender and age above 14 years with
occupational exposure, due to the increased involvement
ofmen and adults in livestock breeding. It also showed amore
frequent familial involvement in occupationally exposed
patients, which reflects the fact that livestock breeding in
our country is usually a family trade. The decreased inci-
dence of anemia in occupationally exposed brucellosis
patients was unexpected since this population has lower
economic standards and an insufficient dietary intake of
nutrients. It is possible that this is attributable to the higheraltitudes in which these patients with direct contact with
animals live.
Regarding the significantly high percentage of localized
forms of the disease, up to this date only one report has
shown them to occur more frequently than we have.24 In both
studies, this was as a result of a higher incidence of osteoar-
ticular localizations. The occurrence of cutaneous and
respiratory forms in patients with occupational exposure
was not high, which is contrary to expectations,20 but agrees
with the observation that the mode of entry is not associated
with the types of clinical manifestations.27 Considering that
the therapeutic protocol comprised two or three drugs, with
good patient compliance and with a duration of no less than
45 days, the percentage of relapses was on the upper limit
described in various reports over the past decades.17,20,29 It is
possible, and has to be taken into account, that some of the
relapses were due to re-infection.17,20,27,30
In conclusion, in the Republic of Macedonia, where bru-
cellosis remains an infection with serious sequelae and public
health implications, we observed some differences in demo-
graphic, clinical and laboratory parameters, but no differ-
ences in the outcome, among patients with and without
occupational exposure. All types of specialists must be famil-
iar with this disease, so that early recognition might result in
lower morbidity. Special efforts need to be made in the areas
of disease control and prevention in animals and in food
control, and public-wide education is necessary.
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